Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Neoplasms | 34 | 2025 | 1262 | 2.760 |
Why?
|
Health Knowledge, Attitudes, Practice | 34 | 2022 | 743 | 2.530 |
Why?
|
Health Surveys | 25 | 2025 | 311 | 1.610 |
Why?
|
Internet | 13 | 2019 | 465 | 1.270 |
Why?
|
United States | 74 | 2025 | 7622 | 1.180 |
Why?
|
Adult | 96 | 2025 | 15972 | 1.140 |
Why?
|
Cooperative Behavior | 10 | 2012 | 220 | 1.090 |
Why?
|
Attitude to Death | 3 | 2013 | 17 | 1.040 |
Why?
|
Health Behavior | 18 | 2020 | 472 | 1.040 |
Why?
|
Health Care Surveys | 10 | 2022 | 281 | 1.020 |
Why?
|
Humans | 174 | 2025 | 60081 | 1.010 |
Why?
|
Patient-Centered Care | 4 | 2022 | 250 | 0.990 |
Why?
|
Communication | 7 | 2022 | 558 | 0.990 |
Why?
|
Adolescent | 60 | 2025 | 5944 | 0.960 |
Why?
|
Middle Aged | 78 | 2025 | 16542 | 0.950 |
Why?
|
Bone Neoplasms | 16 | 1994 | 117 | 0.950 |
Why?
|
Vegetables | 9 | 2015 | 91 | 0.930 |
Why?
|
Surveys and Questionnaires | 31 | 2025 | 2615 | 0.920 |
Why?
|
Fruit | 9 | 2015 | 124 | 0.920 |
Why?
|
Young Adult | 38 | 2025 | 4398 | 0.920 |
Why?
|
Retirement | 1 | 2024 | 17 | 0.910 |
Why?
|
Male | 102 | 2025 | 27951 | 0.870 |
Why?
|
Information Seeking Behavior | 8 | 2025 | 36 | 0.840 |
Why?
|
Female | 104 | 2025 | 31226 | 0.830 |
Why?
|
Athletes | 1 | 2024 | 97 | 0.820 |
Why?
|
Physician-Patient Relations | 4 | 2021 | 395 | 0.800 |
Why?
|
Attitude to Health | 9 | 2013 | 280 | 0.750 |
Why?
|
Patient Acceptance of Health Care | 7 | 2013 | 455 | 0.730 |
Why?
|
National Cancer Institute (U.S.) | 12 | 2024 | 34 | 0.730 |
Why?
|
Health Services Accessibility | 9 | 2019 | 546 | 0.730 |
Why?
|
Sexual and Gender Minorities | 2 | 2020 | 72 | 0.730 |
Why?
|
Public Opinion | 1 | 2020 | 22 | 0.720 |
Why?
|
Information Services | 5 | 2016 | 34 | 0.700 |
Why?
|
Prostatic Neoplasms | 4 | 2020 | 330 | 0.680 |
Why?
|
Quality of Life | 7 | 2019 | 1140 | 0.670 |
Why?
|
Interdisciplinary Communication | 6 | 2012 | 108 | 0.670 |
Why?
|
Neurosurgery | 4 | 2024 | 30 | 0.660 |
Why?
|
Aged | 57 | 2025 | 13596 | 0.660 |
Why?
|
Emigrants and Immigrants | 1 | 2020 | 36 | 0.650 |
Why?
|
Religion and Medicine | 2 | 2019 | 22 | 0.650 |
Why?
|
Perception | 5 | 2020 | 179 | 0.640 |
Why?
|
Cross-Sectional Studies | 23 | 2025 | 2507 | 0.630 |
Why?
|
Papillomaviridae | 1 | 2019 | 60 | 0.620 |
Why?
|
Breast Neoplasms | 6 | 2015 | 1132 | 0.620 |
Why?
|
Group Processes | 5 | 2008 | 41 | 0.610 |
Why?
|
Smoking | 12 | 2016 | 837 | 0.600 |
Why?
|
Mass Screening | 8 | 2020 | 662 | 0.600 |
Why?
|
Patient Participation | 1 | 2020 | 214 | 0.590 |
Why?
|
Papillomavirus Vaccines | 1 | 2019 | 72 | 0.580 |
Why?
|
Tobacco Use | 1 | 2018 | 37 | 0.580 |
Why?
|
Feeding Behavior | 5 | 2015 | 315 | 0.560 |
Why?
|
Schools | 5 | 2022 | 155 | 0.560 |
Why?
|
Papillomavirus Infections | 1 | 2019 | 127 | 0.560 |
Why?
|
Sexual Behavior | 2 | 2018 | 185 | 0.530 |
Why?
|
Research Personnel | 5 | 2008 | 86 | 0.520 |
Why?
|
Uterine Cervical Neoplasms | 2 | 2015 | 146 | 0.510 |
Why?
|
Consumer Health Information | 6 | 2025 | 35 | 0.510 |
Why?
|
Abdominal Pain | 1 | 2016 | 94 | 0.510 |
Why?
|
Healthy People Programs | 4 | 2020 | 11 | 0.500 |
Why?
|
Medical Informatics | 6 | 2019 | 68 | 0.500 |
Why?
|
Brain Neoplasms | 4 | 2015 | 306 | 0.500 |
Why?
|
Health Status | 7 | 2014 | 451 | 0.490 |
Why?
|
Prostate-Specific Antigen | 2 | 2020 | 67 | 0.490 |
Why?
|
Health Communication | 6 | 2019 | 33 | 0.480 |
Why?
|
Neurosurgical Procedures | 2 | 2024 | 94 | 0.480 |
Why?
|
Heart Diseases | 2 | 2014 | 206 | 0.470 |
Why?
|
Goals | 4 | 2020 | 91 | 0.470 |
Why?
|
Weight Loss | 1 | 2016 | 264 | 0.450 |
Why?
|
Socioeconomic Factors | 18 | 2017 | 792 | 0.440 |
Why?
|
Soft Tissue Neoplasms | 9 | 1995 | 31 | 0.430 |
Why?
|
Huntingtin Protein | 3 | 2019 | 138 | 0.430 |
Why?
|
Early Detection of Cancer | 6 | 2020 | 272 | 0.420 |
Why?
|
Research | 2 | 2012 | 190 | 0.420 |
Why?
|
Colorectal Neoplasms | 2 | 2015 | 263 | 0.410 |
Why?
|
Age Factors | 12 | 2020 | 1527 | 0.400 |
Why?
|
Acculturation | 4 | 2015 | 48 | 0.400 |
Why?
|
Biomedical Research | 4 | 2016 | 253 | 0.400 |
Why?
|
Motor Activity | 5 | 2014 | 343 | 0.400 |
Why?
|
Databases, Factual | 3 | 2016 | 850 | 0.400 |
Why?
|
Diabetes Mellitus | 2 | 2014 | 538 | 0.390 |
Why?
|
Cancer Survivors | 2 | 2024 | 80 | 0.380 |
Why?
|
Osteosarcoma | 6 | 1994 | 53 | 0.370 |
Why?
|
Information Dissemination | 4 | 2016 | 119 | 0.370 |
Why?
|
Sex Factors | 9 | 2018 | 971 | 0.360 |
Why?
|
Diet | 8 | 2022 | 638 | 0.360 |
Why?
|
Magnetic Resonance Imaging | 21 | 2015 | 2049 | 0.350 |
Why?
|
Nutrition Surveys | 8 | 2016 | 153 | 0.340 |
Why?
|
Radiotherapy, Intensity-Modulated | 1 | 2010 | 34 | 0.330 |
Why?
|
Nutrition Policy | 4 | 2014 | 49 | 0.330 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2010 | 56 | 0.330 |
Why?
|
Radiosurgery | 1 | 2010 | 61 | 0.320 |
Why?
|
Prevalence | 6 | 2018 | 1299 | 0.320 |
Why?
|
Neoplasms, Multiple Primary | 6 | 1993 | 29 | 0.320 |
Why?
|
Therapy, Computer-Assisted | 1 | 2008 | 24 | 0.310 |
Why?
|
Logistic Models | 10 | 2022 | 1262 | 0.300 |
Why?
|
Survivors | 3 | 2016 | 148 | 0.300 |
Why?
|
Electronic Health Records | 3 | 2017 | 354 | 0.300 |
Why?
|
Hypertension | 1 | 2014 | 603 | 0.300 |
Why?
|
Psychometrics | 3 | 2025 | 359 | 0.300 |
Why?
|
Mass Media | 4 | 2013 | 31 | 0.290 |
Why?
|
User-Computer Interface | 1 | 2008 | 131 | 0.290 |
Why?
|
Cognition | 1 | 2012 | 466 | 0.290 |
Why?
|
Diet Surveys | 5 | 2011 | 78 | 0.290 |
Why?
|
Food Preferences | 3 | 2013 | 55 | 0.290 |
Why?
|
Global Health | 3 | 2024 | 165 | 0.290 |
Why?
|
Health Promotion | 7 | 2012 | 490 | 0.280 |
Why?
|
Reproducibility of Results | 7 | 2025 | 1565 | 0.280 |
Why?
|
Trust | 4 | 2020 | 69 | 0.280 |
Why?
|
Ovarian Neoplasms | 2 | 2019 | 138 | 0.280 |
Why?
|
Data Collection | 7 | 2020 | 383 | 0.270 |
Why?
|
Meningeal Neoplasms | 3 | 2015 | 57 | 0.260 |
Why?
|
Meningioma | 3 | 2015 | 58 | 0.260 |
Why?
|
Exercise | 6 | 2022 | 919 | 0.260 |
Why?
|
Patient Satisfaction | 4 | 2015 | 419 | 0.260 |
Why?
|
Multiple Chronic Conditions | 2 | 2017 | 37 | 0.260 |
Why?
|
Social Support | 4 | 2015 | 366 | 0.240 |
Why?
|
Smoking Cessation | 3 | 2013 | 538 | 0.240 |
Why?
|
Personal Satisfaction | 2 | 2024 | 78 | 0.240 |
Why?
|
Genetic Therapy | 4 | 2022 | 742 | 0.230 |
Why?
|
Tomography, X-Ray Computed | 14 | 2016 | 1481 | 0.230 |
Why?
|
RNA, Small Interfering | 2 | 2021 | 855 | 0.230 |
Why?
|
Body Mass Index | 4 | 2017 | 892 | 0.230 |
Why?
|
Pediatric Obesity | 2 | 2017 | 99 | 0.230 |
Why?
|
Alcohol Drinking | 3 | 2022 | 305 | 0.230 |
Why?
|
Vocabulary, Controlled | 2 | 2016 | 11 | 0.230 |
Why?
|
Colonic Neoplasms | 4 | 2009 | 216 | 0.230 |
Why?
|
Food Services | 2 | 2014 | 29 | 0.220 |
Why?
|
Huntington Disease | 2 | 2018 | 146 | 0.220 |
Why?
|
Lung Neoplasms | 7 | 2013 | 579 | 0.220 |
Why?
|
Micronutrients | 1 | 2024 | 29 | 0.220 |
Why?
|
Spinal Dysraphism | 1 | 2024 | 16 | 0.220 |
Why?
|
Educational Status | 7 | 2017 | 273 | 0.220 |
Why?
|
Professional-Patient Relations | 3 | 2016 | 128 | 0.220 |
Why?
|
Fanconi Anemia | 2 | 2013 | 15 | 0.220 |
Why?
|
Family | 3 | 2013 | 224 | 0.210 |
Why?
|
Giant Cell Tumors | 3 | 1992 | 5 | 0.210 |
Why?
|
Food Supply | 2 | 2015 | 74 | 0.210 |
Why?
|
Sibling Relations | 1 | 2002 | 5 | 0.210 |
Why?
|
Bias | 3 | 2022 | 106 | 0.210 |
Why?
|
Child | 17 | 2022 | 4313 | 0.200 |
Why?
|
Factor Analysis, Statistical | 1 | 2022 | 105 | 0.200 |
Why?
|
Physicians, Family | 3 | 1991 | 75 | 0.200 |
Why?
|
Tibia | 4 | 1992 | 70 | 0.200 |
Why?
|
Parent-Child Relations | 1 | 2002 | 63 | 0.200 |
Why?
|
Behavioral Research | 1 | 2022 | 15 | 0.200 |
Why?
|
Radiography | 12 | 2010 | 514 | 0.190 |
Why?
|
Motivation | 1 | 2024 | 270 | 0.190 |
Why?
|
Diagnosis, Differential | 8 | 2016 | 908 | 0.190 |
Why?
|
Tay-Sachs Disease | 1 | 2022 | 34 | 0.190 |
Why?
|
Developing Countries | 2 | 2024 | 85 | 0.190 |
Why?
|
Self Efficacy | 4 | 2016 | 199 | 0.190 |
Why?
|
Guideline Adherence | 3 | 2014 | 298 | 0.190 |
Why?
|
Beverages | 3 | 2017 | 65 | 0.190 |
Why?
|
Parents | 3 | 2013 | 389 | 0.190 |
Why?
|
Biological Warfare | 1 | 2001 | 3 | 0.190 |
Why?
|
Bioterrorism | 1 | 2001 | 11 | 0.190 |
Why?
|
Neostriatum | 2 | 2018 | 25 | 0.190 |
Why?
|
Risk Assessment | 6 | 2015 | 1936 | 0.180 |
Why?
|
Risk | 3 | 2017 | 376 | 0.180 |
Why?
|
Models, Organizational | 4 | 2008 | 93 | 0.180 |
Why?
|
Science | 4 | 2008 | 34 | 0.180 |
Why?
|
Glioblastoma | 3 | 2015 | 156 | 0.180 |
Why?
|
National Institutes of Health (U.S.) | 4 | 2016 | 113 | 0.180 |
Why?
|
Dependovirus | 5 | 2022 | 659 | 0.180 |
Why?
|
Disaster Planning | 1 | 2001 | 51 | 0.180 |
Why?
|
Dacarbazine | 2 | 2010 | 20 | 0.180 |
Why?
|
Decision Making | 3 | 2013 | 394 | 0.180 |
Why?
|
Health Records, Personal | 2 | 2017 | 26 | 0.170 |
Why?
|
Self Report | 2 | 2014 | 369 | 0.170 |
Why?
|
California | 4 | 2014 | 161 | 0.170 |
Why?
|
Uncertainty | 2 | 2013 | 33 | 0.170 |
Why?
|
Salpingo-oophorectomy | 1 | 2019 | 3 | 0.170 |
Why?
|
Registries | 4 | 2024 | 811 | 0.170 |
Why?
|
Genetic Predisposition to Disease | 3 | 2017 | 677 | 0.170 |
Why?
|
Military Personnel | 1 | 2001 | 97 | 0.170 |
Why?
|
Students | 1 | 2022 | 208 | 0.170 |
Why?
|
Consumer Behavior | 2 | 2010 | 35 | 0.170 |
Why?
|
Telemedicine | 2 | 2020 | 337 | 0.170 |
Why?
|
Multivariate Analysis | 6 | 2017 | 928 | 0.170 |
Why?
|
Hemangioma | 5 | 1994 | 28 | 0.170 |
Why?
|
Aged, 80 and over | 11 | 2019 | 5200 | 0.170 |
Why?
|
Risk Factors | 11 | 2015 | 5090 | 0.160 |
Why?
|
Vulnerable Populations | 1 | 2020 | 87 | 0.160 |
Why?
|
Access to Information | 2 | 2016 | 30 | 0.160 |
Why?
|
Fibroma | 4 | 1991 | 12 | 0.160 |
Why?
|
Delivery of Health Care | 3 | 2022 | 424 | 0.160 |
Why?
|
Choice Behavior | 2 | 2017 | 77 | 0.150 |
Why?
|
Muscular Diseases | 3 | 1994 | 47 | 0.150 |
Why?
|
Time-to-Treatment | 1 | 2019 | 100 | 0.150 |
Why?
|
Quality of Health Care | 2 | 2015 | 524 | 0.150 |
Why?
|
Bolivia | 2 | 2017 | 2 | 0.150 |
Why?
|
Obesity | 5 | 2014 | 1191 | 0.150 |
Why?
|
Putamen | 1 | 2018 | 19 | 0.150 |
Why?
|
Caudate Nucleus | 1 | 2018 | 25 | 0.150 |
Why?
|
Femoral Neoplasms | 3 | 1992 | 5 | 0.150 |
Why?
|
Carbonated Beverages | 2 | 2017 | 20 | 0.150 |
Why?
|
Mutant Proteins | 1 | 2018 | 105 | 0.140 |
Why?
|
Biomarkers | 2 | 2014 | 1214 | 0.140 |
Why?
|
Pancreatic Neoplasms | 2 | 1992 | 328 | 0.140 |
Why?
|
Sheep | 4 | 2021 | 168 | 0.140 |
Why?
|
Sweetening Agents | 1 | 2017 | 25 | 0.140 |
Why?
|
Central Nervous System | 1 | 2019 | 192 | 0.140 |
Why?
|
Skin Neoplasms | 4 | 2009 | 405 | 0.140 |
Why?
|
Prophylactic Surgical Procedures | 1 | 2017 | 2 | 0.140 |
Why?
|
Internationality | 1 | 2017 | 42 | 0.140 |
Why?
|
Salpingectomy | 1 | 2017 | 5 | 0.140 |
Why?
|
Anesthesia | 1 | 2017 | 52 | 0.140 |
Why?
|
Genes, BRCA1 | 1 | 2017 | 19 | 0.140 |
Why?
|
Genes, BRCA2 | 1 | 2017 | 14 | 0.140 |
Why?
|
Ovariectomy | 1 | 2017 | 97 | 0.140 |
Why?
|
Virus Internalization | 1 | 2018 | 99 | 0.140 |
Why?
|
Patient Education as Topic | 2 | 2019 | 450 | 0.140 |
Why?
|
Wireless Technology | 1 | 2016 | 18 | 0.140 |
Why?
|
Medical Informatics Computing | 1 | 2016 | 1 | 0.140 |
Why?
|
Survival Rate | 2 | 2016 | 793 | 0.130 |
Why?
|
Common Data Elements | 1 | 2016 | 5 | 0.130 |
Why?
|
Life Style | 3 | 2014 | 330 | 0.130 |
Why?
|
Obstetrics | 1 | 2017 | 87 | 0.130 |
Why?
|
Caregivers | 2 | 2012 | 232 | 0.130 |
Why?
|
Physicians | 1 | 2021 | 442 | 0.130 |
Why?
|
Health Education | 4 | 2013 | 184 | 0.130 |
Why?
|
Surgical Procedures, Operative | 1 | 2017 | 139 | 0.130 |
Why?
|
Hand Strength | 1 | 2016 | 29 | 0.130 |
Why?
|
Odds Ratio | 7 | 2011 | 774 | 0.130 |
Why?
|
Urban Population | 1 | 2017 | 185 | 0.130 |
Why?
|
Smoking Prevention | 4 | 2013 | 162 | 0.130 |
Why?
|
Physical Fitness | 1 | 2016 | 92 | 0.130 |
Why?
|
Convection | 2 | 2013 | 10 | 0.120 |
Why?
|
Longitudinal Studies | 2 | 2018 | 1239 | 0.120 |
Why?
|
Contrast Media | 3 | 2015 | 414 | 0.120 |
Why?
|
Neurons | 2 | 2018 | 861 | 0.120 |
Why?
|
Chondrosarcoma | 2 | 1994 | 6 | 0.120 |
Why?
|
Demeclocycline | 1 | 2015 | 4 | 0.120 |
Why?
|
Thigh | 7 | 1994 | 25 | 0.120 |
Why?
|
Tobacco Use Disorder | 2 | 2008 | 245 | 0.120 |
Why?
|
Time Factors | 6 | 2013 | 3621 | 0.120 |
Why?
|
Public Health | 2 | 2014 | 180 | 0.120 |
Why?
|
Interviews as Topic | 6 | 2014 | 495 | 0.120 |
Why?
|
Rural Population | 1 | 2017 | 193 | 0.120 |
Why?
|
Legislation, Food | 1 | 2014 | 3 | 0.120 |
Why?
|
Recommended Dietary Allowances | 1 | 2014 | 11 | 0.120 |
Why?
|
Wounds and Injuries | 1 | 2017 | 243 | 0.120 |
Why?
|
Osteoma, Osteoid | 2 | 1991 | 3 | 0.120 |
Why?
|
Child, Preschool | 10 | 2015 | 1839 | 0.120 |
Why?
|
Ischium | 1 | 1994 | 3 | 0.120 |
Why?
|
Food Dispensers, Automatic | 2 | 2013 | 2 | 0.120 |
Why?
|
Genetic Vectors | 3 | 2018 | 818 | 0.120 |
Why?
|
Chronic Disease | 2 | 2017 | 744 | 0.110 |
Why?
|
Microscopy, Confocal | 1 | 2015 | 221 | 0.110 |
Why?
|
Education, Medical, Graduate | 1 | 2017 | 319 | 0.110 |
Why?
|
Ki-67 Antigen | 1 | 2014 | 34 | 0.110 |
Why?
|
Computational Biology | 1 | 2016 | 337 | 0.110 |
Why?
|
Resistance Training | 1 | 2014 | 20 | 0.110 |
Why?
|
Eating | 1 | 2015 | 139 | 0.110 |
Why?
|
Taxes | 1 | 2013 | 6 | 0.110 |
Why?
|
Behavioral Sciences | 1 | 2013 | 2 | 0.110 |
Why?
|
Accelerometry | 1 | 2014 | 59 | 0.110 |
Why?
|
Primary Prevention | 2 | 2013 | 137 | 0.110 |
Why?
|
Famous Persons | 1 | 2013 | 8 | 0.110 |
Why?
|
Anxiety | 3 | 2008 | 400 | 0.110 |
Why?
|
Quality-Adjusted Life Years | 1 | 2014 | 61 | 0.110 |
Why?
|
Antineoplastic Agents, Alkylating | 2 | 2010 | 31 | 0.110 |
Why?
|
Models, Economic | 1 | 2013 | 42 | 0.110 |
Why?
|
Glioma | 2 | 2015 | 102 | 0.110 |
Why?
|
Disease Models, Animal | 3 | 2018 | 2074 | 0.110 |
Why?
|
Stem Cell Transplantation | 1 | 2013 | 74 | 0.110 |
Why?
|
Guidelines as Topic | 1 | 2014 | 158 | 0.110 |
Why?
|
Sarcoma, Ewing | 1 | 1993 | 11 | 0.110 |
Why?
|
Mathematics | 1 | 2012 | 28 | 0.100 |
Why?
|
Papanicolaou Test | 2 | 2009 | 41 | 0.100 |
Why?
|
Vaginal Smears | 2 | 2009 | 53 | 0.100 |
Why?
|
Information Storage and Retrieval | 2 | 2013 | 80 | 0.100 |
Why?
|
Community Participation | 2 | 2012 | 44 | 0.100 |
Why?
|
Gene Expression Regulation | 1 | 2019 | 1542 | 0.100 |
Why?
|
Cost-Benefit Analysis | 1 | 2014 | 302 | 0.100 |
Why?
|
Meaningful Use | 1 | 2012 | 8 | 0.100 |
Why?
|
Physical Education and Training | 1 | 2012 | 31 | 0.100 |
Why?
|
Corpus Striatum | 1 | 2013 | 93 | 0.100 |
Why?
|
Financing, Organized | 1 | 2012 | 16 | 0.100 |
Why?
|
Coffee | 1 | 1992 | 19 | 0.100 |
Why?
|
Neuronavigation | 1 | 2011 | 13 | 0.100 |
Why?
|
Community Networks | 2 | 2008 | 29 | 0.100 |
Why?
|
Activities of Daily Living | 1 | 2014 | 301 | 0.100 |
Why?
|
MicroRNAs | 1 | 2018 | 617 | 0.100 |
Why?
|
Health Literacy | 1 | 2012 | 77 | 0.100 |
Why?
|
Population Surveillance | 2 | 2010 | 206 | 0.090 |
Why?
|
Animals, Genetically Modified | 3 | 2018 | 281 | 0.090 |
Why?
|
Fasciitis | 1 | 1991 | 2 | 0.090 |
Why?
|
Risk-Taking | 4 | 2016 | 159 | 0.090 |
Why?
|
Preventive Medicine | 1 | 1991 | 25 | 0.090 |
Why?
|
Efficiency, Organizational | 1 | 2012 | 95 | 0.090 |
Why?
|
Cone-Beam Computed Tomography | 1 | 2011 | 71 | 0.090 |
Why?
|
Consensus | 3 | 2019 | 199 | 0.090 |
Why?
|
Biomarkers, Tumor | 1 | 2014 | 466 | 0.090 |
Why?
|
Health Services Research | 1 | 2012 | 270 | 0.090 |
Why?
|
Thoracic Arteries | 1 | 1990 | 3 | 0.090 |
Why?
|
Activating Transcription Factors | 1 | 2010 | 10 | 0.090 |
Why?
|
Mammary Arteries | 1 | 1990 | 11 | 0.090 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2010 | 44 | 0.090 |
Why?
|
Mediastinum | 1 | 1990 | 25 | 0.090 |
Why?
|
Immobilization | 1 | 2010 | 12 | 0.090 |
Why?
|
Amyloid Precursor Protein Secretases | 1 | 2010 | 67 | 0.090 |
Why?
|
Breast | 1 | 2012 | 173 | 0.090 |
Why?
|
Behavioral Risk Factor Surveillance System | 2 | 2008 | 48 | 0.090 |
Why?
|
Hematopoietic Stem Cell Transplantation | 1 | 2013 | 329 | 0.090 |
Why?
|
Communications Media | 1 | 2009 | 2 | 0.080 |
Why?
|
Tumor Burden | 1 | 2010 | 62 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 98 | 0.080 |
Why?
|
Arm | 1 | 1990 | 38 | 0.080 |
Why?
|
Computer Communication Networks | 2 | 2008 | 13 | 0.080 |
Why?
|
Patient Positioning | 1 | 2010 | 43 | 0.080 |
Why?
|
Aneurysm | 1 | 1990 | 54 | 0.080 |
Why?
|
Human papillomavirus 6 | 1 | 2009 | 4 | 0.080 |
Why?
|
Condylomata Acuminata | 1 | 2009 | 9 | 0.080 |
Why?
|
Colonography, Computed Tomographic | 1 | 2009 | 20 | 0.080 |
Why?
|
Follow-Up Studies | 2 | 2019 | 2360 | 0.080 |
Why?
|
Histological Techniques | 1 | 1989 | 18 | 0.080 |
Why?
|
Retrospective Studies | 8 | 2014 | 6147 | 0.080 |
Why?
|
Genital Neoplasms, Female | 1 | 2009 | 19 | 0.080 |
Why?
|
Program Evaluation | 2 | 2008 | 488 | 0.080 |
Why?
|
Animals | 9 | 2021 | 19739 | 0.080 |
Why?
|
Regression Analysis | 2 | 2011 | 483 | 0.080 |
Why?
|
Mental Health | 1 | 2012 | 349 | 0.080 |
Why?
|
Sex Distribution | 4 | 2011 | 255 | 0.080 |
Why?
|
Linear Models | 2 | 2009 | 423 | 0.080 |
Why?
|
Insurance, Health | 1 | 2010 | 143 | 0.080 |
Why?
|
Analysis of Variance | 2 | 2009 | 576 | 0.080 |
Why?
|
Chi-Square Distribution | 1 | 2009 | 406 | 0.080 |
Why?
|
Diagnostic Errors | 1 | 1989 | 98 | 0.080 |
Why?
|
Drug Delivery Systems | 1 | 2011 | 311 | 0.080 |
Why?
|
Mental Processes | 1 | 2008 | 18 | 0.070 |
Why?
|
Sick Role | 1 | 2007 | 15 | 0.070 |
Why?
|
Puerto Rico | 3 | 2014 | 233 | 0.070 |
Why?
|
Brain | 2 | 2015 | 1485 | 0.070 |
Why?
|
Algorithms | 2 | 2010 | 1006 | 0.070 |
Why?
|
Genome, Viral | 2 | 2018 | 122 | 0.070 |
Why?
|
Ganglionic Stimulants | 1 | 2007 | 5 | 0.070 |
Why?
|
Disruptive, Impulse Control, and Conduct Disorders | 1 | 2007 | 8 | 0.070 |
Why?
|
Cotinine | 1 | 2007 | 18 | 0.070 |
Why?
|
Friends | 1 | 2007 | 29 | 0.070 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2010 | 406 | 0.070 |
Why?
|
Cosmetic Techniques | 1 | 2006 | 8 | 0.070 |
Why?
|
Cosmetics | 1 | 2006 | 17 | 0.070 |
Why?
|
Gene Expression Profiling | 1 | 2010 | 713 | 0.070 |
Why?
|
Women's Health | 1 | 2009 | 390 | 0.070 |
Why?
|
Testicular Neoplasms | 1 | 2006 | 32 | 0.070 |
Why?
|
RNA, Messenger | 3 | 2019 | 1465 | 0.070 |
Why?
|
Skin Pigmentation | 1 | 2006 | 32 | 0.070 |
Why?
|
Attention | 1 | 2008 | 151 | 0.070 |
Why?
|
Depression | 2 | 2016 | 868 | 0.060 |
Why?
|
Social Perception | 1 | 2006 | 36 | 0.060 |
Why?
|
Sheep, Domestic | 2 | 2018 | 13 | 0.060 |
Why?
|
Physician's Role | 1 | 2007 | 120 | 0.060 |
Why?
|
Genetic Testing | 1 | 2006 | 131 | 0.060 |
Why?
|
Overweight | 1 | 2008 | 249 | 0.060 |
Why?
|
Nicotine | 1 | 2007 | 111 | 0.060 |
Why?
|
Substance Withdrawal Syndrome | 1 | 2007 | 119 | 0.060 |
Why?
|
Confidence Intervals | 3 | 2011 | 257 | 0.060 |
Why?
|
Infant | 5 | 2013 | 1522 | 0.060 |
Why?
|
Neoplasm Grading | 2 | 2015 | 76 | 0.060 |
Why?
|
Respiration Disorders | 1 | 2005 | 21 | 0.060 |
Why?
|
Marijuana Smoking | 1 | 2005 | 16 | 0.060 |
Why?
|
Bone and Bones | 3 | 1992 | 156 | 0.060 |
Why?
|
Incidence | 2 | 2024 | 1267 | 0.060 |
Why?
|
Pilot Projects | 2 | 2024 | 930 | 0.060 |
Why?
|
Evaluation Studies as Topic | 1 | 2004 | 104 | 0.060 |
Why?
|
Sunscreening Agents | 3 | 2009 | 21 | 0.060 |
Why?
|
Food | 2 | 2015 | 80 | 0.060 |
Why?
|
State Government | 2 | 2014 | 32 | 0.060 |
Why?
|
World Health Organization | 1 | 2024 | 30 | 0.060 |
Why?
|
Food, Fortified | 1 | 2024 | 21 | 0.060 |
Why?
|
Religion | 1 | 2004 | 33 | 0.060 |
Why?
|
Fear | 1 | 2004 | 67 | 0.050 |
Why?
|
Qualitative Research | 3 | 2013 | 633 | 0.050 |
Why?
|
Suicide | 1 | 2004 | 124 | 0.050 |
Why?
|
Cohort Studies | 2 | 2019 | 2480 | 0.050 |
Why?
|
Drug Administration Routes | 1 | 2021 | 20 | 0.050 |
Why?
|
Neuroticism | 1 | 2021 | 2 | 0.050 |
Why?
|
Commerce | 1 | 2022 | 59 | 0.050 |
Why?
|
Policy | 1 | 2022 | 48 | 0.050 |
Why?
|
Radius | 2 | 1992 | 13 | 0.050 |
Why?
|
Arthritis, Infectious | 2 | 1991 | 19 | 0.050 |
Why?
|
Hazardous Substances | 1 | 2001 | 16 | 0.050 |
Why?
|
Humerus | 2 | 1992 | 9 | 0.050 |
Why?
|
Anticonvulsants | 1 | 2022 | 95 | 0.050 |
Why?
|
Civil Defense | 1 | 2001 | 12 | 0.050 |
Why?
|
Prospective Studies | 2 | 2019 | 3133 | 0.050 |
Why?
|
Disease Outbreaks | 1 | 2001 | 104 | 0.040 |
Why?
|
Acquired Immunodeficiency Syndrome | 2 | 1991 | 137 | 0.040 |
Why?
|
Culture | 2 | 2013 | 76 | 0.040 |
Why?
|
Communicable Diseases | 1 | 2001 | 83 | 0.040 |
Why?
|
Health Policy | 1 | 2022 | 183 | 0.040 |
Why?
|
Fibrous Dysplasia of Bone | 2 | 1990 | 5 | 0.040 |
Why?
|
Mutation | 2 | 2019 | 2466 | 0.040 |
Why?
|
Patella | 2 | 1990 | 13 | 0.040 |
Why?
|
Tumor Cells, Cultured | 2 | 2010 | 453 | 0.040 |
Why?
|
Mice | 4 | 2019 | 10317 | 0.040 |
Why?
|
Biopsy | 3 | 2015 | 375 | 0.040 |
Why?
|
Residence Characteristics | 2 | 2012 | 230 | 0.040 |
Why?
|
Cell Phone | 1 | 2019 | 43 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 2 | 2010 | 302 | 0.040 |
Why?
|
History, 21st Century | 1 | 2019 | 166 | 0.040 |
Why?
|
Mobile Applications | 1 | 2020 | 130 | 0.040 |
Why?
|
Wool | 1 | 2018 | 5 | 0.040 |
Why?
|
Electrolytes | 1 | 2018 | 24 | 0.040 |
Why?
|
Internal Capsule | 1 | 2018 | 12 | 0.040 |
Why?
|
Immunoassay | 1 | 2018 | 52 | 0.040 |
Why?
|
Serogroup | 1 | 2018 | 32 | 0.040 |
Why?
|
Injections | 1 | 2018 | 79 | 0.040 |
Why?
|
Demography | 2 | 2010 | 178 | 0.040 |
Why?
|
Emergency Medical Services | 1 | 2001 | 251 | 0.040 |
Why?
|
Capacity Building | 1 | 2017 | 22 | 0.040 |
Why?
|
Case-Control Studies | 2 | 2009 | 1064 | 0.040 |
Why?
|
Radionuclide Imaging | 2 | 2015 | 116 | 0.040 |
Why?
|
Dietary Sucrose | 1 | 2017 | 30 | 0.030 |
Why?
|
Cell Line, Tumor | 2 | 2010 | 1387 | 0.030 |
Why?
|
Green Fluorescent Proteins | 1 | 2018 | 354 | 0.030 |
Why?
|
Risk Reduction Behavior | 1 | 2017 | 125 | 0.030 |
Why?
|
United States Food and Drug Administration | 1 | 2016 | 95 | 0.030 |
Why?
|
Patient Preference | 1 | 2016 | 77 | 0.030 |
Why?
|
Semantics | 1 | 2016 | 58 | 0.030 |
Why?
|
Joint Diseases | 1 | 1995 | 18 | 0.030 |
Why?
|
Kidney | 1 | 2018 | 397 | 0.030 |
Why?
|
Referral and Consultation | 1 | 2019 | 409 | 0.030 |
Why?
|
Cost of Illness | 1 | 2016 | 157 | 0.030 |
Why?
|
Lipoma | 2 | 1995 | 18 | 0.030 |
Why?
|
Epidemiologic Methods | 1 | 2015 | 69 | 0.030 |
Why?
|
Pituitary Neoplasms | 1 | 2015 | 24 | 0.030 |
Why?
|
Feasibility Studies | 1 | 2017 | 531 | 0.030 |
Why?
|
Faculty, Medical | 1 | 2017 | 203 | 0.030 |
Why?
|
Microglia | 1 | 2018 | 229 | 0.030 |
Why?
|
Societies, Medical | 1 | 2017 | 342 | 0.030 |
Why?
|
Shoulder | 2 | 1992 | 23 | 0.030 |
Why?
|
Sampling Studies | 2 | 1991 | 66 | 0.030 |
Why?
|
Lymphedema | 1 | 2014 | 7 | 0.030 |
Why?
|
Neoplasm Metastasis | 1 | 2015 | 196 | 0.030 |
Why?
|
Diagnostic Imaging | 2 | 1994 | 242 | 0.030 |
Why?
|
Waist Circumference | 1 | 2014 | 53 | 0.030 |
Why?
|
Postmenopause | 1 | 2015 | 246 | 0.030 |
Why?
|
Optical Imaging | 1 | 2015 | 68 | 0.030 |
Why?
|
Child Behavior | 1 | 2014 | 68 | 0.030 |
Why?
|
Hotlines | 1 | 2013 | 22 | 0.030 |
Why?
|
Gender Identity | 1 | 2014 | 61 | 0.030 |
Why?
|
Computer Security | 1 | 2013 | 12 | 0.030 |
Why?
|
Extremities | 2 | 1991 | 50 | 0.030 |
Why?
|
Statistics as Topic | 1 | 2014 | 146 | 0.030 |
Why?
|
Treatment Outcome | 2 | 2017 | 5266 | 0.030 |
Why?
|
Liver | 1 | 2018 | 785 | 0.030 |
Why?
|
Fatigue | 1 | 2014 | 104 | 0.030 |
Why?
|
Health Status Disparities | 1 | 2015 | 146 | 0.030 |
Why?
|
Internal-External Control | 1 | 2013 | 32 | 0.030 |
Why?
|
Fluorescent Dyes | 1 | 2015 | 197 | 0.030 |
Why?
|
Chondroblastoma | 2 | 1993 | 2 | 0.030 |
Why?
|
C-Reactive Protein | 1 | 2014 | 168 | 0.030 |
Why?
|
Exercise Therapy | 1 | 2014 | 102 | 0.030 |
Why?
|
Geographic Information Systems | 1 | 2013 | 21 | 0.030 |
Why?
|
Curriculum | 1 | 2017 | 569 | 0.030 |
Why?
|
Software | 1 | 2016 | 376 | 0.030 |
Why?
|
Stereotaxic Techniques | 1 | 2013 | 29 | 0.030 |
Why?
|
Cholesterol | 1 | 2014 | 255 | 0.030 |
Why?
|
Myxoma | 2 | 1989 | 14 | 0.030 |
Why?
|
Canada | 1 | 2013 | 149 | 0.030 |
Why?
|
Family Characteristics | 1 | 2012 | 44 | 0.030 |
Why?
|
Adolescent Behavior | 1 | 2014 | 189 | 0.030 |
Why?
|
Body Weight | 1 | 2014 | 381 | 0.030 |
Why?
|
Triglycerides | 1 | 2014 | 242 | 0.030 |
Why?
|
Metacarpus | 1 | 1992 | 1 | 0.030 |
Why?
|
Metatarsus | 1 | 1992 | 1 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2015 | 1037 | 0.030 |
Why?
|
Ulna | 1 | 1992 | 4 | 0.030 |
Why?
|
Fibula | 1 | 1992 | 9 | 0.030 |
Why?
|
Geography | 1 | 2012 | 32 | 0.030 |
Why?
|
Utah | 1 | 1992 | 7 | 0.020 |
Why?
|
Fingers | 1 | 1992 | 42 | 0.020 |
Why?
|
Sarcoma, Synovial | 1 | 1992 | 6 | 0.020 |
Why?
|
Tea | 1 | 1992 | 26 | 0.020 |
Why?
|
Seat Belts | 1 | 1991 | 11 | 0.020 |
Why?
|
Fluoroscopy | 1 | 2011 | 62 | 0.020 |
Why?
|
Pelvic Bones | 1 | 1991 | 14 | 0.020 |
Why?
|
Sunlight | 1 | 1991 | 29 | 0.020 |
Why?
|
Preconception Care | 1 | 1991 | 24 | 0.020 |
Why?
|
Hip Joint | 1 | 1991 | 35 | 0.020 |
Why?
|
Bone Cysts | 2 | 1989 | 6 | 0.020 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 1992 | 65 | 0.020 |
Why?
|
Blood-Brain Barrier | 1 | 2011 | 81 | 0.020 |
Why?
|
Healthcare Disparities | 1 | 2015 | 332 | 0.020 |
Why?
|
Forearm | 1 | 1991 | 19 | 0.020 |
Why?
|
Sensitivity and Specificity | 1 | 2014 | 1100 | 0.020 |
Why?
|
Mycobacterium avium-intracellulare Infection | 1 | 1991 | 8 | 0.020 |
Why?
|
Wrist Joint | 1 | 1991 | 8 | 0.020 |
Why?
|
Rectum | 1 | 1991 | 85 | 0.020 |
Why?
|
Energy Intake | 1 | 2012 | 213 | 0.020 |
Why?
|
Gadolinium | 1 | 2011 | 102 | 0.020 |
Why?
|
Carmustine | 1 | 2010 | 10 | 0.020 |
Why?
|
Spinal Neoplasms | 1 | 1990 | 15 | 0.020 |
Why?
|
Sexually Transmitted Diseases | 1 | 1991 | 94 | 0.020 |
Why?
|
Actigraphy | 1 | 2011 | 47 | 0.020 |
Why?
|
Spheroids, Cellular | 1 | 2010 | 26 | 0.020 |
Why?
|
DNA, Complementary | 1 | 2010 | 162 | 0.020 |
Why?
|
Benzenesulfonates | 1 | 2010 | 14 | 0.020 |
Why?
|
Myeloid Cell Leukemia Sequence 1 Protein | 1 | 2010 | 19 | 0.020 |
Why?
|
Niacinamide | 1 | 2010 | 32 | 0.020 |
Why?
|
Dipeptides | 1 | 2010 | 61 | 0.020 |
Why?
|
Phenylurea Compounds | 1 | 2010 | 30 | 0.020 |
Why?
|
Mice, Nude | 1 | 2010 | 260 | 0.020 |
Why?
|
Cell Adhesion | 1 | 2010 | 208 | 0.020 |
Why?
|
Signal Transduction | 2 | 2010 | 2892 | 0.020 |
Why?
|
Osteitis Deformans | 1 | 1990 | 2 | 0.020 |
Why?
|
Fractures, Bone | 1 | 1991 | 150 | 0.020 |
Why?
|
Transplantation, Heterologous | 1 | 2010 | 225 | 0.020 |
Why?
|
DNA Primers | 1 | 2010 | 290 | 0.020 |
Why?
|
Insulin | 1 | 2014 | 692 | 0.020 |
Why?
|
Neoplasm Transplantation | 1 | 2010 | 160 | 0.020 |
Why?
|
Social Change | 1 | 2009 | 13 | 0.020 |
Why?
|
Xenograft Model Antitumor Assays | 1 | 2010 | 183 | 0.020 |
Why?
|
Online Systems | 1 | 2009 | 21 | 0.020 |
Why?
|
Receptors, Notch | 1 | 2010 | 100 | 0.020 |
Why?
|
Blogging | 1 | 2009 | 10 | 0.020 |
Why?
|
Exons | 1 | 2010 | 190 | 0.020 |
Why?
|
Bone Diseases | 1 | 1990 | 21 | 0.020 |
Why?
|
Occult Blood | 1 | 2009 | 16 | 0.020 |
Why?
|
Radiographic Image Enhancement | 1 | 1990 | 98 | 0.020 |
Why?
|
Electronic Mail | 1 | 2010 | 46 | 0.020 |
Why?
|
Pyridines | 1 | 2010 | 98 | 0.020 |
Why?
|
Internship and Residency | 1 | 2017 | 748 | 0.020 |
Why?
|
Nutrition Assessment | 1 | 2009 | 58 | 0.020 |
Why?
|
Cell Culture Techniques | 1 | 2010 | 179 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2013 | 713 | 0.020 |
Why?
|
Evidence-Based Practice | 1 | 2010 | 82 | 0.020 |
Why?
|
Cell Death | 1 | 2010 | 272 | 0.020 |
Why?
|
Cell Division | 1 | 2010 | 442 | 0.020 |
Why?
|
Telephone | 1 | 2009 | 121 | 0.020 |
Why?
|
Health Services | 1 | 2009 | 85 | 0.020 |
Why?
|
Colonoscopy | 1 | 2009 | 104 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 525 | 0.020 |
Why?
|
Institutional Management Teams | 1 | 2008 | 3 | 0.020 |
Why?
|
Time Management | 1 | 2008 | 9 | 0.020 |
Why?
|
Empirical Research | 1 | 2008 | 14 | 0.020 |
Why?
|
Creativity | 1 | 2008 | 13 | 0.020 |
Why?
|
Muscles | 1 | 1989 | 172 | 0.020 |
Why?
|
Censuses | 1 | 2008 | 15 | 0.020 |
Why?
|
Income | 1 | 2009 | 162 | 0.020 |
Why?
|
Social Class | 1 | 2009 | 126 | 0.020 |
Why?
|
Models, Psychological | 1 | 2008 | 93 | 0.020 |
Why?
|
Individuality | 1 | 2008 | 21 | 0.020 |
Why?
|
SEER Program | 1 | 2008 | 68 | 0.020 |
Why?
|
Attitude | 1 | 2008 | 101 | 0.020 |
Why?
|
Organizational Innovation | 1 | 2008 | 84 | 0.020 |
Why?
|
Mental Recall | 1 | 2008 | 94 | 0.020 |
Why?
|
Interprofessional Relations | 1 | 2008 | 134 | 0.020 |
Why?
|
Administration, Intranasal | 1 | 2007 | 28 | 0.020 |
Why?
|
Patient Compliance | 1 | 2009 | 373 | 0.020 |
Why?
|
Self-Help Groups | 1 | 2007 | 37 | 0.020 |
Why?
|
Mammography | 1 | 2009 | 273 | 0.020 |
Why?
|
RNA Interference | 1 | 2010 | 592 | 0.020 |
Why?
|
Beauty Culture | 1 | 2006 | 16 | 0.020 |
Why?
|
Protective Clothing | 1 | 2006 | 29 | 0.020 |
Why?
|
Radiation Protection | 1 | 2006 | 25 | 0.020 |
Why?
|
Evidence-Based Medicine | 1 | 2009 | 457 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2007 | 281 | 0.020 |
Why?
|
Prognosis | 1 | 2010 | 1591 | 0.020 |
Why?
|
Sunburn | 1 | 2006 | 11 | 0.020 |
Why?
|
Antineoplastic Agents | 1 | 2010 | 646 | 0.020 |
Why?
|
Adaptation, Psychological | 1 | 2007 | 264 | 0.020 |
Why?
|
Respiratory Sounds | 1 | 2005 | 20 | 0.010 |
Why?
|
Research Design | 1 | 2008 | 569 | 0.010 |
Why?
|
Apoptosis | 1 | 2010 | 1042 | 0.010 |
Why?
|
Spirometry | 1 | 2005 | 94 | 0.010 |
Why?
|
Dyspnea | 1 | 2005 | 110 | 0.010 |
Why?
|
Massachusetts | 1 | 2010 | 2119 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2010 | 3215 | 0.010 |
Why?
|
Cough | 1 | 2005 | 183 | 0.010 |
Why?
|
Hospitalization | 1 | 2010 | 1304 | 0.010 |
Why?
|
Liposarcoma | 2 | 1991 | 9 | 0.010 |
Why?
|
Synovial Cyst | 1 | 1995 | 1 | 0.010 |
Why?
|
Cartilage, Articular | 1 | 1995 | 74 | 0.010 |
Why?
|
Preoperative Care | 1 | 1995 | 177 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 1995 | 460 | 0.010 |
Why?
|
Image Enhancement | 1 | 1995 | 191 | 0.010 |
Why?
|
Osteochondroma | 1 | 1993 | 3 | 0.010 |
Why?
|
Chondroma | 1 | 1993 | 3 | 0.010 |
Why?
|
Diatrizoate Meglumine | 1 | 1991 | 5 | 0.010 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 1 | 1991 | 16 | 0.010 |
Why?
|
Enema | 1 | 1991 | 12 | 0.010 |
Why?
|
Medical History Taking | 1 | 1991 | 59 | 0.010 |
Why?
|
Substance Abuse, Intravenous | 1 | 1991 | 75 | 0.010 |
Why?
|
Back Pain | 1 | 1990 | 51 | 0.010 |
Why?
|
Histiocytoma, Benign Fibrous | 1 | 1990 | 1 | 0.010 |
Why?
|
Lipomatosis | 1 | 1990 | 8 | 0.010 |
Why?
|
Alkaline Phosphatase | 1 | 1990 | 42 | 0.010 |
Why?
|
Neurofibroma | 1 | 1989 | 2 | 0.010 |
Why?
|
Synovitis, Pigmented Villonodular | 1 | 1989 | 3 | 0.010 |
Why?
|
Epidermal Cyst | 1 | 1989 | 10 | 0.010 |
Why?
|
Angiography | 1 | 1990 | 145 | 0.010 |
Why?
|
Nervous System Diseases | 1 | 1990 | 104 | 0.000 |
Why?
|
Abscess | 1 | 1989 | 75 | 0.000 |
Why?
|
Staphylococcal Infections | 1 | 1989 | 116 | 0.000 |
Why?
|